Cedars-Sinai Medical Center Beverly Hills

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
SAMe in Prevention of Oxaliplatin-associated Liver Injury	5-fluorouracil toxicity, Chemically-Induced Disorders, Chemically-Induced Liver Toxicity, Digestive System Diseases, Digestive System Neoplasms, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, cardiovascular disorder, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, drug-induced liver injury, hepatic veno-occlusive disease, intestinal disorder, liver disorder, neoplasm, poisoning, rectal disorder, vascular disorder	Not yet recruiting	Phase 2	2026-09-30		NCT06258525
Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer	Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma	Recruiting	Phase 2	2026-08-04		NCT07017673

Clinical trials